Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms
Inflammatory Bowel Diseases · 23.05.2024 · 30 (Supplement_2) · S5-S18
DOI: 10.1093/ibd/izae081 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 23.05.2024. Verfasst von Matthew A Ciorba und 15 weiteren Autor:innen. Beteiligte Einrichtung: Inflammatory Bowel Diseases Center, Division of Gastroenterology, Washington University in St. Louis, Saint Louis, MO, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, Merck.
Abstract (Originalsprache)
Preclinical human inflammatory bowel disease (IBD) mechanisms is one of 5 focus areas of the Challenges in IBD Research 2024 document, which also includes environmental triggers, novel technologies, precision medicine, and pragmatic clinical research. Herein, we provide a comprehensive overview of current gaps in inflammatory bowel diseases research that relate to preclinical research and deliver actionable approaches to address them with a focus on how these gaps can lead to advancements in IBD interception, remission, and restoration. The document is the result of multidisciplinary input from scientists, clinicians, patients, and funders and represents a valuable resource for patient-centric research prioritization. This preclinical human IBD mechanisms section identifies major research gaps whose investigation will elucidate pathways and mechanisms that can be targeted to address unmet medical needs in IBD. Research gaps were identified in the following areas: genetics, risk alleles, and epigenetics; the microbiome; cell states and interactions; barrier function; IBD complications (specifically fibrosis and stricturing); and extraintestinal manifestations. To address these gaps, we share specific opportunities for investigation for basic and translational scientists and identify priority actions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inflammatory Bowel Diseases Center, Division of Gastroenterology, Washington University in St. Louis, Saint Louis, MO, USA.
- Departments of Pediatrics, Immunobiology, and Obstetric, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
- Snyder Institute for Chronic Diseases, Dept. of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
- The Leona M. and Harry B. Helmsley Charitable Trust, New York, NY, USA.
- Departments of Pathology and Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Kymera Therapeutics, Watertown, MA, USA.
ORCID-Profile: Andrés Hurtado-Lorenzo, Jennifer L Swantek
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- Merck
- Astellas
- Incyte
- Janssen
- Pfizer
- NIH
Zitieren
APA
Ciorba, M. A., Konnikova, L., Hirota, S. A., Lucchetta, E. M., Turner, J. R., Slavin, A., Johnson, K., Condray, C. D., Hong, S., Cressall, B. K., Pizarro, T. T., Hurtado-Lorenzo, A., Heller, C. A., Moss, A. C., Swantek, J. L., & Garrett, W. S. (2024). Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms. Inflammatory Bowel Diseases, 30(Supplement_2), S5-S18. https://doi.org/10.1093/ibd/izae081
Vancouver
Ciorba MA, Konnikova L, Hirota SA, Lucchetta EM, Turner JR, Slavin A, et al. Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms. Inflammatory Bowel Diseases. 2024;30(Supplement_2):S5-S18. doi:10.1093/ibd/izae081
BibTeX
@article{Ciorba2024,
author = {Ciorba, Matthew A and Konnikova, Liza and Hirota, Simon A and Lucchetta, Elena M and Turner, Jerrold R and Slavin, Anthony and Johnson, Kristen and Condray, Cass D and Hong, Sungmo and Cressall, Brandon K and Pizarro, Theresa T and Hurtado-Lorenzo, Andrés and Heller, Caren A and Moss, Alan C and Swantek, Jennifer L and Garrett, Wendy S},
title = {Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms},
journal = {Inflammatory Bowel Diseases},
year = {2024},
volume = {30},
number = {Supplement_2},
pages = {S5--S18},
doi = {10.1093/ibd/izae081}
}
EUVIMED